Justin C. Frankel, P.C., represented a client with Chronic Lymphocytic Leukemia whose long-term disability benefits ...

Nurix Therapeutics, Inc. (NASDAQ:NRIX) is one of the Best Small Cap Stocks Ready to Explode in 2026. On January 21, Robert ...

Istanbul, Turkey, January 29, 2026 -- Liv Hospital International continues to strengthen its specialized hematology and ...

Adopting zanubrutinib for the treatment of chronic lymphocytic leukemia showed improved tolerability and persistence, ...

Better treatment and earlier diagnosis mean that 7 in 10 people will survive five years or more after a cancer diagnosis.

Oncoscope launches the first Real-time, AI-supported Living Systematic Literature Review designed for enterprise-wide ...

In November 2025, Nurix appointed accomplished biopharmaceutical leader Roger Dansey, M.D., to its Board of Directors, adding ...

HBV coinfection with acute exacerbation was associated with significantly worse survival outcomes in pediatric T-ALL.

After adjustment for other factors, a CFS of 3 or higher and relapsed/refractory disease were the only independent predictors of early zanubrutinib discontinuation.

Eli Lilly Canada, Inc announced today that Jaypirca® (pirtobrutinib, 100 mg & 50 mg tablets) is now approved and available ...

Hulk Hogan isn’t actually spending much time doing anything these days… because the legendary WWE wrestler died last year.

Scientists at the Broad Institute and Mass General Brigham have built a generative AI model that creates short DNA segments ...